Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (73)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mueller, A.
Right arrow Articles by Williams, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mueller, A.
Right arrow Articles by Williams, D. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, 2000, Vol. 10, No. 4 339-346
© 2000 Oxford University Press

The influence of glucan polymer structure and solution conformation on binding to (1->3)-ß-D-glucan receptors in a human monocyte-like cell line

Antje Mueller2,6, John Raptis2,6, Peter J. Rice3,6, John H. Kalbfleisch4,6, Robert D. Stout5,6, Harry E. Ensley7, William Browder2 and David L. Williams1,2,6

Departments of 2Surgery, 3Pharmacology, 4Medical Education, 5Microbiology, and 6Immunopharmacology Research Group, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614–0575, USA and 7Department of Chemistry, Tulane University, New Orleans, LA 70115, USA

Glucans are (1–3)-ß-D-linked polymers of glucose that are produced as fungal cell wall constituents and are also released into the extracellular milieu. Glucans modulate immune function via macrophage participation. The first step in macrophage activation by (1–3)-ß-D-glucans is thought to be the binding of the polymer to specific macrophage receptors. We examined the binding/uptake of a variety of water soluble (1–3)-ß-D-glucans and control polymers with different physicochemical properties to investigate the relationship between polymer structure and receptor binding in the CR3- human promonocytic cell line, U937. We observed that the U937 receptors were specific for (1->3)-ß-D-glucan binding, since mannan, dextran, or barley glucan did not bind. Scleroglucan exhibited the highest binding affinity with an IC50 of 23 nM, three orders of magnitude greater than the other (1->3)-ß-D-glucan polymers examined. The rank order competitive binding affinities for the glucan polymers were scleroglucan>>>schizophyllan > laminarin > glucan phosphate > glucan sulfate. Scleroglucan also exhibited a triple helical solution structure ({nu} = 1.82, ß = 0.8). There were two different binding/uptake sites on U937 cells. Glucan phosphate and schizophyllan interacted nonselectively with the two sites. Scleroglucan and glucan sulfate interacted preferentially with one site, while laminarin interacted preferentially with the other site. These data indicate that U937 cells have at least two non-CR3 receptor(s) which specifically interact with (1->3)-ß-D-glucans and that the triple helical solution conformation, molecular weight and charge of the glucan polymer may be important determinants in receptor ligand interaction.

1 To whom correspondence should be addressed at: Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37604–0575


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
E. L. Adams, P. J. Rice, B. Graves, H. E. Ensley, H. Yu, G. D. Brown, S. Gordon, M. A. Monteiro, E. Papp-Szabo, D. W. Lowman, et al.
Differential High-Affinity Interaction of Dectin-1 with Natural or Synthetic Glucans Is Dependent upon Primary Structure and Is Influenced by Polymer Chain Length and Side-Chain Branching
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 115 - 123.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
A. H. Lacchini, A. J. Davies, D. Mackintosh, and A. J. Walker
{beta}-1, 3-glucan modulates PKC signalling in Lymnaea stagnalis defence cells: a role for PKC in H2O2 production and downstream ERK activation
J. Exp. Biol., December 15, 2006; 209(24): 4829 - 4840.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. R. Ozment-Skelton, M. P. Goldman, S. Gordon, G. D. Brown, and D. L. Williams
Prolonged Reduction of Leukocyte Membrane-Associated Dectin-1 Levels following beta-Glucan Administration
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 540 - 546.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. J. Rice, E. L. Adams, T. Ozment-Skelton, A. J. Gonzalez, M. P. Goldman, B. E. Lockhart, L. A. Barker, K. F. Breuel, W. K. DePonti, J. H. Kalbfleisch, et al.
Oral Delivery and Gastrointestinal Absorption of Soluble Glucans Stimulate Increased Resistance to Infectious Challenge
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1079 - 1086.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Herre, A. S. J. Marshall, E. Caron, A. D. Edwards, D. L. Williams, E. Schweighoffer, V. Tybulewicz, C. R. e Sousa, S. Gordon, and G. D. Brown
Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages
Blood, December 15, 2004; 104(13): 4038 - 4045.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. T. Borchers, C. L. Keen, and M. E. Gershwin
Mushrooms, Tumors, and Immunity: An Update
Experimental Biology and Medicine, May 1, 2004; 229(5): 393 - 406.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
I. L. Ahren, E. Eriksson, A. Egesten, and K. Riesbeck
Nontypeable Haemophilus influenzae Activates Human Eosinophils through {beta}-Glucan Receptors
Am. J. Respir. Cell Mol. Biol., November 1, 2003; 29(5): 598 - 605.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
F. Lebron, R. Vassallo, V. Puri, and A. H. Limper
Pneumocystis carinii Cell Wall {beta}-Glucans Initiate Macrophage Inflammatory Responses through NF-{kappa}B Activation
J. Biol. Chem., June 27, 2003; 278(27): 25001 - 25008.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. J. Rice, J. L. Kelley, G. Kogan, H. E. Ensley, J. H. Kalbfleisch, I. W. Browder, and D. L. Williams
Human monocyte scavenger receptors are pattern recognition receptors for (1->3)-{beta}-D-glucans
J. Leukoc. Biol., July 1, 2002; 72(1): 140 - 146.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N.-K. V. Cheung and S. Modak
Oral (1->3),(1->4)-{beta}-D-Glucan Synergizes with Antiganglioside GD2 Monoclonal Antibody 3F8 in the Therapy of Neuroblastoma
Clin. Cancer Res., May 1, 2002; 8(5): 1217 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. Kougias, D. Wei, P. J. Rice, H. E. Ensley, J. Kalbfleisch, D. L. Williams, and I. W. Browder
Normal Human Fibroblasts Express Pattern Recognition Receptors for Fungal (1{right-arrow}3)-{beta}-D-Glucans
Infect. Immun., June 1, 2001; 69(6): 3933 - 3938.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.